Whole-body, blood and patient-specific dosimetry of radioiodine in the treatment of differentiated thyroid cancer.

被引：0
|
作者：
Haq, M
Pratt, B
Harmer, C
Flux, G
机构：
[1] Royal Marsden Hosp, Dept Phys, Sutton, Surrey, England
[2] Royal Marsden Hosp, Head Thyroid Unit, Sutton, Surrey, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S466 / S467
页数：2
相关论文
共 50 条
  • [1] Dosimetry during radioiodine therapy in metastatic differentiated thyroid cancer.
    Castellani, M. R.
    Chiesa, C.
    Botta, F.
    Azzeroni, R.
    Negri, A.
    Mansi, D.
    Maccauro, M.
    Orunesu, E.
    Seregni, E.
    Bombardieri, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [2] Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
    Klain, Michele
    Nappi, Carmela
    De Risi, Marina
    Piscopo, Leandra
    Volpe, Fabio
    Manganelli, Mariarosaria
    Caiazzo, Elisa
    Bianco, Davide
    Schlumberger, Martin
    Cuocolo, Alberto
    [J]. DIAGNOSTICS, 2021, 11 (10)
  • [3] Generating Patient-Specific Dosimetry Phantoms with Whole-Body Diffeomorphic Image Registration
    Tward, D. J.
    Ceritoglu, C.
    Sturgeon, G.
    Segars, W. P.
    Miller, M. I.
    Ratnanather, J. T.
    [J]. 2011 IEEE 37TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC), 2011,
  • [4] Patient-specific whole-body dosimetry: Principles and a simplified method for clinical implementation
    Wahl, RL
    Kroll, S
    Zasadny, KR
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (08): : 14S - 20S
  • [5] Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma
    Haenscheid, Heribert
    Lassmann, Michael
    Luster, Markus
    Kloos, Richard T.
    Reiners, Christoph
    [J]. ENDOCRINE-RELATED CANCER, 2009, 16 (04) : 1283 - 1289
  • [6] Radioiodine whole body scan pitfalls in differentiated thyroid cancer
    Basso, Cristina
    Colapinto, Alessandra
    Vicennati, Valentina
    Gambineri, Alessandra
    Pelusi, Carla
    Di Dalmazi, Guido
    Rizzini, Elisa Lodi
    Tabacchi, Elena
    Golemi, Arber
    Calderoni, Letizia
    Fanti, Stefano
    Pagotto, Uberto
    Repaci, Andrea
    [J]. ENDOCRINE, 2024, 85 (02) : 493 - 508
  • [7] Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer
    Chong, Ari
    Seo, Youngduk
    Bang, Ji-In
    Park, Sohyun
    Kim, Keunyoung
    Hong, Chae Moon
    Choi, Miyoung
    Oh, So Won
    Lee, Sang-Woo
    [J]. CLINICAL NUCLEAR MEDICINE, 2024, 49 (03) : 215 - 225
  • [8] Patient-specific anatomical models for radioiodine dosimetry in treatment of hyperthyroidism: is it necessary?
    Khalili, Susan
    Miri-Hakimabad, Hashem
    Hoseinian-Azghadi, Elie
    [J]. MEDICAL PHYSICS, 2020, 47 (10) : 5357 - 5365
  • [9] Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
    Deandreis, Desiree
    Rubino, Carole
    Tala, Hernan
    Leboulleux, Sophie
    Terroir, Marie
    Baudin, Eric
    Larson, Steve
    Fagin, James A.
    Schlumberger, Martin
    Tuttle, R. Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05): : 717 - 722
  • [10] Effect of furosemide on whole-body radioactivity retention in patients treated with radioiodine (RAI) for differentiated thyroid cancer (DTC)
    Criscuoli, B.
    Rossi, G.
    Follacchio, G.
    Manni, C.
    Castagnoli, H.
    Fattori, S.
    Capoccetti, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S148 - S148
12345